Dr. Alan Bell
Type of Practice:
Family Medicine

Education Associations

Assistant Professor Family and Community Medicine, University of Toronto


Dr. Bell is a family physician and clinical researcher in Toronto, Canada. He is Assistant Professor in the Department of Family and Community Medicine, University of Toronto. He is a recipient of the Canadian College of Family Physicians Award of Excellence.

Dr. Bell has incorporated cannabis based medicine in his clinical practice since 2001 when the MMAR (Marihuana Medical Access Regulations) were first enacted. He has been actively involved in teaching and advocacy of CBM to health care professionals and the public since that time.

His other activities include:
• Thrombosis Canada – Board of Directors and Vice President
• Hypertension Canada – Board of Directors and Co-chair of Education and Implementation
• Canadian Cardiovascular Society – Primary Panel and Past Chair
• Antiplatelet Guideline Committee.
• Canadian Cardiovascular Society – Primary Panel
• Atrial Fibrillation Guideline Committee

Dr. Bell is the only primary care physician to chair a CCS guideline committee. His involvement in continuing medical education includes the development and presentation of many national projects. He has served as faculty and chair of countless committees and advisory boards dedicated to serving the common interests of the medical profession and the public. His research, commentaries and letters have been presented and published internationally.


Bhaskar A, Bell A, et al. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res. 2021 Jul 2;3(1):22. doi: 10.1186/s42238-021-00073-1.

Sihota A, Smith BK, Ahmed SA, Bell A, Blain A, Clarke H, Cooper ZD, Cyr C, Daeninck P, Deshpande A, Ethans K, Flusk D, Le Foll B, Milloy MJ, Moulin DE, Naidoo V, Ong M, Perez J, Rod K, Sealey R, Sulak D, Walsh Z, O’Connell C. Consensus-Based Recommendations for Titrating Cannabinoids and Tapering Opioids for Chronic Pain Control. Int J Clin Pract. 2020 Nov 28:e13871. doi: 10.1111/ijcp.13871.

Wright P, Walsh Z, Margolese S, Sanchez T, Arlt S, Belle-Isle L, St Pierre M, Bell A, Daeninck P, Gagnon M, Lacasse G, MacCallum C, Mandarino E, Yale J, O’Hara J, Costiniuk C. Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review. BMJ Open. 2020 May 24;10(5):e036114